{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:59Z","timestamp":1707525659627},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,22]]},"DOI":"10.7759\/cureus.52729","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T14:43:26Z","timestamp":1705934606000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Distal Common Bile Duct Obstruction Due to a Neuroendocrine Tumor"],"prefix":"10.7759","author":[{"given":"Ramsey","family":"Rayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omeed","family":"Partovi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Strohbeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta L","family":"Bureau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Giorgadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Asmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Shah MH","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB, et al.. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:10.6004\/jnccn.2021.0032","journal-title":"J Natl Compr Canc Netw"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi G","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, et al.. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018, 31:1770-86. 10.1038\/s41379-018-0110-y","journal-title":"Mod Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/000313480807400121","article-title":"Carcinoid of the extra-hepatic bile duct: a case report with long-term follow-up and review of literature","volume":"74","author":"Gusani NJ","year":"2008","unstructured":"Gusani NJ, Marsh JW, Nalesnik MA, Tublin ME, Gamblin TC. Carcinoid of the extra-hepatic bile duct: a case report with long-term follow-up and review of literature. Am Surg. 2008, 74:87-90. 10.1177\/000313480807400121","journal-title":"Am Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","author":"Ramage JK","year":"2012","unstructured":"Ramage JK, Ahmed A, Ardill J, et al.. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012, 61:6-32. 10.1136\/gutjnl-2011-300831","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-014-9808-4","article-title":"Neuroendocrine tumors of extrahepatic biliary tract","volume":"20","author":"Michalopoulos N","year":"2014","unstructured":"Michalopoulos N, Papavramidis TS, Karayannopoulou G, Pliakos I, Papavramidis ST, Kanellos I. Neuroendocrine tumors of extrahepatic biliary tract. Pathol Oncol Res. 2014, 20:765-75. 10.1007\/s12253-014-9808-4","journal-title":"Pathol Oncol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","article-title":"An analysis of 8305 cases of carcinoid tumors","volume":"79","author":"Modlin IM","year":"1997","unstructured":"Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997, 79:813-29. 10.1002\/(SICI)1097-0142(19970215)79:4&lt;813::AID-CNCR19&gt;3.0.CO;2-2","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari A","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al.. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017, 3:1335-42. 10.1001\/jamaoncol.2017.0589","journal-title":"JAMA Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin IM","year":"2003","unstructured":"Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003, 97:934-59. 10.1002\/cncr.11105","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2006.03.028","article-title":"Differential diagnosis of proximal biliary obstruction","volume":"140","author":"Are C","year":"2006","unstructured":"Are C, Gonen M, D'Angelica M, DeMatteo RP, Fong Y, Blumgart LH, Jarnagin WR. Differential diagnosis of proximal biliary obstruction. Surgery. 2006, 140:756-63. 10.1016\/j.surg.2006.03.028","journal-title":"Surgery"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2018.09.004","article-title":"Dilemma of elevated CA 19-9 in biliary pathology","volume":"18","author":"Tsen A","year":"2018","unstructured":"Tsen A, Barbara M, Rosenkranz L. Dilemma of elevated CA 19-9 in biliary pathology. Pancreatology. 2018, 18:862-7. 10.1016\/j.pan.2018.09.004","journal-title":"Pancreatology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2023.01.009","article-title":"Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms","volume":"23","author":"Gao C","year":"2023","unstructured":"Gao C, Fan Z, Yang J, Shi M, Li Y, Zhan H. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Pancreatology. 2023, 23:204-12. 10.1016\/j.pan.2023.01.009","journal-title":"Pancreatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb17255.x","article-title":"Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival","volume":"733","author":"Oberg K","year":"1994","unstructured":"Oberg K. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Ann N Y Acad Sci. 1994, 733:46-55. 10.1111\/j.1749-6632.1994.tb17255.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/02841868909111201","article-title":"Chromogranins\u2014new sensitive markers for neuroendocrine tumors","volume":"28","author":"Eriksson B","year":"1989","unstructured":"Eriksson B, Arnberg H, Oberg K, Hellman U, Lundqvist G, Wernstedt C, Wilander E. Chromogranins\u2014new sensitive markers for neuroendocrine tumors. Acta Oncol. 1989, 28:325-9. 10.3109\/02841868909111201","journal-title":"Acta Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09647-z","article-title":"\"Present and future of immunotherapy in neuroendocrine tumors\"","volume":"22","author":"Albertelli M","year":"2021","unstructured":"Albertelli M, Dotto A, Nista F, et al.. \"Present and future of immunotherapy in neuroendocrine tumors\". Rev Endocr Metab Disord. 2021, 22:615-36. 10.1007\/s11154-021-09647-z","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/191122-a-case-of-distal-common-bile-duct-obstruction-due-to-a-neuroendocrine-tumor","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:11Z","timestamp":1707509531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/191122-a-case-of-distal-common-bile-duct-obstruction-due-to-a-neuroendocrine-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.52729","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,22]]}}}